Clerio Vision, Inc.

Clerio Vision, Inc.: Novel ophthalmic technology to treat refractive error addressing multi-billion contact lens and corneal vision correction markets. Based on Nobel Prize winning femto-second laser technology developed by Bausch & Lomb and the University of Rochester. Contact lens approval expected mid-2022, clinical studies ongoing for presbyopia, hyperopia and myopia. Recently signed $1B silicon hydrogel contact lens partnership with a leading eye care company. Clerio's non-surgical flapless corneal vision correction solution expected to unlock LASIK market opportunity. $70M raised to date.
Sector/Industry:
Healthcare
Characteristics:
Based in...
US - Middle Atlantic
Clinical Stage
Phase III
Disease Space
Ophthalmology
Finance
Revenues
Industry
Medical Device, Medical Technology
Investement Strategy
Under the Radar
Listing
Private
Website:
Profiles:
Address:
1892 S. Winton Rd.
Rochester, NY 14618
United States

Upcoming Company Event Participation